Medical Devices & Diagnostics · LP-212
IV cannula Medical device
Device / diagnostic development record. Review the proposed presentation and the professional reference information below.
Development record
- Portfolio reference
- LP-212Medical Devices & Diagnostics
- Product type
- IV cannulaMedical device
- Registration
- Not establishedProduct-specific evidence required
- Availability
- Not marketedNo offer of supply
01 · Product-type reference
Record identity and reference background.
- Portfolio reference
- LP-212
- Product type
- IV cannula
- Device presentation
- Medical device
- Configuration / specification
- 18G; 20G; 22G; 24G
- Proposed pack
- Sterile single-use pack
- Portfolio category
- Medical Devices & Diagnostics
About IV cannula
An intravenous cannula is a vascular-access medical device used by trained healthcare personnel. It can provide temporary peripheral venous access when clinically indicated. It is not a medicine, and gauge alone does not describe all of its performance or safety characteristics. Material, length, design, intended use and compatibility must be established for the particular device.
How to read this profile
Scientific information relates to the device or diagnostic type. It is not approved Luang Pharma labelling, a clinical recommendation, or evidence of equivalence to a referenced product. Multiple strengths or presentations represent separate proposed variants and must not be treated as interchangeable.
02 · Professional background
Scientific & clinical reference
Read the clinical context, selected safety considerations and presentation-specific information below.
Intended-use context
Clinical selection considers the patient’s veins, required therapy, expected duration and the properties of the fluid or medicine. A smaller or larger gauge is not automatically better. Correct selection is one part of an infection-prevention and vascular-access programme that includes surveillance of the site and removal when no longer needed. The catalogue does not establish flow rate, pressure-injection suitability, needle-safety features or use in a particular age group.
Important safety considerations
Potential complications include infiltration, extravasation, phlebitis, bleeding and infection. Needlestick injury and blood exposure are occupational risks. Pain, swelling, leakage, redness or signs of systemic illness require assessment. A damaged or expired sterile pack must not be used. Single-use devices must not be reprocessed unless a specific lawful, validated system applies; no reprocessing suitability is claimed here. Access care requires appropriate clinical observation.
These are selected considerations, not a complete list. Use the current instructions or approved label for the exact authorised product and seek appropriate professional advice.
Presentation, handling and storage
The source lists gauges and a sterile single-use pack. Verify catheter material and length, connector standard, any safety mechanism, latex status, sterilization method and compatibility claims from the authorized device documentation.
Keep the cannula in its intact sterile barrier until use and inspect packaging and expiry. Use according to the model-specific instructions and institutional aseptic policy. Dispose of sharps and used components through appropriate clinical waste systems, retaining lot information for traceability.
Final composition, instructions, shelf life and storage conditions are not established by this portfolio entry. They must come from the controlled documentation for the specific product.
Points for professional review
Confirm the therapy, patient and access requirements, device registration and relevant performance data. Ensure trained users, aseptic practice, site monitoring and traceability.
03 · Product enquiry
Documentation & regulatory status
Evidence status
What is established — and what remains open
This record has received an editorial evidence-layer review. The review separates catalogue facts from unresolved product-specific fields and external context; it is not medical, regulatory or market-authorisation approval.
Layer 01
Controlled catalogue facts
- Device / diagnostic type
- IV cannula
- Presentation
- Medical device
- Catalogue configuration
- 18G; 20G; 22G; 24G
- Catalogue pack
- Sterile single-use pack
- Portfolio category
- Medical Devices & Diagnostics
Layer 02
Unresolved product-specific fields
- P024 — Gauge values 18G, 20G, 22G and 24G do not establish catheter material, length, flow rate, pressure capability, hub/connector design, safety mechanism, sterilization method or intended-use duration.
- The sterile single-use pack statement remains a controlled catalogue fact; model-specific sterility validation, shelf life and conformity evidence are still required.
- Approved indication, patient eligibility and dosing or test interpretation are not established by this portfolio record.
- Registration/authorization, manufacturing or site status, supply availability, storage conditions and shelf life remain product- and market-specific evidence items.
Layer 03
Attributed external context
- FDA 510(k) database: example short-term intravascular catheter systemgovernment device-database example
These references provide scientific or regulatory context only. They are not Luang Pharma product labelling, registration, manufacturing evidence, equivalence evidence or confirmation of supply.
Layer 04
Documents required to close the record
- Exact manufacturer/model specification and IFU establishing intended use, technical configuration, performance limits, accessories/compatibility, warnings, storage, shelf life and sterilization where applicable.
- Destination-market device/IVD classification and authorization/conformity evidence for the exact model; generic FDA/WHO references are not evidence for the Luang record.
- Model-specific quality/performance verification and current packaging/label artwork before any public certification, accuracy, sterility or compatibility claim.
- Manufacturing/supply-status evidence before any claim that the device is produced, stocked, registered or available through Luang Pharma.
For LP-212, identify the destination country, intended professional use, proposed presentation and the role of your organisation. The appropriate supply route and available documentation must be confirmed for that case.
- Confirm the legal entity, manufacturing site and authorised scope for the proposed supply chain.
- Confirm device classification, intended use, conformity evidence and local import requirements.
- Request relevant product information, specifications and supporting evidence through the company contact.
- Confirm storage, transport, traceability, complaints and safety-reporting responsibilities before any agreement.
The public catalogue extends beyond the initial planned facility modules. A listing does not mean that the dosage form is installed, qualified or licensed at Boten.
04 · External sources
Sources and further reading
External sources are provided for reference. Their authors do not endorse Luang Pharma, and another product’s authorisation does not transfer to this portfolio record. Source availability and wording can change.
Professional enquiries
Request product-specific evidence for LP-212.
State the exact presentation, organisation, destination and evidence needed. This public record is not an offer of supply.